Philosophy of Care
I believe in a multidisciplinary approach to managing chronic diseases and empowering patients through education abut their condition.
My primary goals are to ensure that my patients have the best possible quality of life and survival by providing access to all appropriate therapies for their heart failure and to help them understand their condition so that they become members of the care team.
Dr. Tong's clinical interests rest in the management of heart failure patients, an expanding population in the United States.
Research over the last two decades has brought the medical community many effective pharmaceutical and surgical treatments for heart failure, and patients currently have a better chance at having a meaningful quality of life than ever before.
I am currently involved in a research project that evaluates the effectiveness of a multidisciplinary strategy in the transition of care of heart failure patients from the inpatient to the outpatient setting.
I have additional training in advanced heart failure therapies such as heart transplantation and mechanical assist devices so that I can help patients who are at the end stages of their disease navigate all possible treatment options.
Director of Heart Failure Program
Director of the Preventative Cardiology and Cardiac Rehabilitation Program
Medical Director of the Ventricular Assist Device Progam
B.S., UC Davis, Davis CA 1998
Advanced Heart Failure and Heart Transplantation, UC San Francisco Medical Center, San Francisco CA 2009-2010
American Board of Internal Medicine, Advanced Heart Failure and Heart Transplantation,
American Board of Internal Medicine, Cardiovascular Medicine,
Select Honors and Awards:
Chancellor's Award for Excellence in Residency, UC Davis Medical Center, 2006
Select Recent Publications:
Wettersten N, Wilson M, Tong K, Lopez J. Enhanced Prediction of Heart Failure 30-Day Readmission Risk With Four Readily-Available Clinical Variables. Circulation. 2014;130: A17063 .
Tong K, Myers S, Poole P, Nguyen J, Griffin E, Levich B. A Multidisciplinary Approach at the Primary Care Level Improves Heart Failure Care. J of Cardiac Failure. 2013;19:8, S42–S43.
Tong, KL, Ports T, McGlothlin D, Brown, C, De Marco T. Alcohol Septal Ablation To Treat Heart Failure Due to Dynamic Left Ventricular Outflow Tract Obstruction in a Patient With Glycogen Storage Disease Related to the PRKAG2 Gene Mutation. J of Cardiac Failure. 2010;16(8) S110.
Tong K, Hoppe B, Amsterdam A, Yang Y, Srivatsa U. Stroke Risk in Patients with Cardiac Resynchronization Therapy from the ADVANCENT Heart Failure Registry: Not Related to Atrial Fibrillation in Those Older Than 75 Years. J of Cardiac Failure. 2009;15(6).
Tong KL, McGlothlin D, Leard L, Golden J, DeMarco T, Hoopes CH. Lung Transplantation for Pulmonary Arterial Hypertension Associated with Human Immunodeficiency Virus Infection. Presented at the annual International Society for Heart and Lung Transplantation meeting in Chicago on April 23, 2010.